Bird & Bird advised Bpifrance’s Large Venture on Series A financing round of Bioptimus, a specialist in AI applied to innovation in biomedicine

International law firm Bird & Bird advised Bpifrance's Large Venture on its participation in the $41 million Series A financing round of Bioptimus, a biotech company that specialises in AI applied to innovation in biomedicine.

Bpifrance's Large Venture participated alongside Cathay Innovation, who led the round, and Sofinnova Partners, an existing investor, in the Series A financing round, one year after the $35 million Seed round.

The Bird & Bird team consisted of partner Carole Bodin and associate Céline Sol for corporate aspects.

Bioptimus was advised by Jones Day, with partner Renaud Bonnet alongside associates, Jérémie Noel and Vincent Babin.

Bird & Bird, who also advised on Large Venture on its first financing round of Bioptimus, is a regular advisor to Bpifrance.

News & Deals

More News & Deals

Deal

Bird & Bird advises gaming studio Dead Astronauts AB on seed round

Feb 11 2025

Read More

News

Bird & Bird strengthens Finance Services Sector Group in France with new partner

Feb 10 2025

Read More

Deal

Bird & Bird advises Gamma on the agreement to acquire STARFACE from Maxburg

Feb 07 2025

Read More

Deal

Bird & Bird advised the African Development Bank on $100 million financing of Sucden

Feb 04 2025

Read More

News

Bird & Bird hires Susan Battye to lead the employment practice in Ireland

Jan 28 2025

Read More

Deal

Bird & Bird and Sheppard Mullin Represent Buyers in the Majority Sale of Championship Football Club, Swansea City AFC

Jan 27 2025

Read More